Literature DB >> 8600816

31P nuclear magnetic resonance analysis of phospholipids in a ternary homogeneous system.

M Branca1, N Culeddu, M Fruianu, M V Serra.   

Abstract

We analyzed the changes in the shape and resonance positions of the 31P NMR signals of phospholipid mixtures in a single-phase solvent containing different quantities of chloroform, methanol, and water. We obtained extremely reproducible NMR signals when sufficient care was taken to control the desired solvent composition. The solvent composition can be predicted using a "tie line" in a ternary diagram of chloroform, methanol, and water or by mixing the three components at the desired ratio. Avoiding the presence of a biphasic system allows easy solvent preparation and NMR spectral reproducibility, with the possibility of complete recovery of the sample and absence of loses due to different repartition coefficients.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8600816     DOI: 10.1006/abio.1995.9968

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  4 in total

1.  Competition between Li+ and Mg2+ for red blood cell membrane phospholipids: A 31P, 7Li, and 6Li nuclear magnetic resonance study.

Authors:  C Srinivasan; N Minadeo; C F Geraldes; D Mota de Freitas
Journal:  Lipids       Date:  1999-11       Impact factor: 1.880

Review 2.  Principles of multiparametric optimization for phospholipidomics by 31P NMR spectroscopy.

Authors:  Norbert W Lutz; Patrick J Cozzone
Journal:  Biophys Rev       Date:  2013-02-26

3.  Quantitative characterization of phospholipids in milk fat via 31P NMR using a monophasic solvent mixture.

Authors:  Sergio Murgia; Stefania Mele; Maura Monduzzi
Journal:  Lipids       Date:  2003-05       Impact factor: 1.880

4.  NMR studies of lipid regulation of the K+ channel KcsA.

Authors:  Dongyu Zhang; Gary S Howarth; Lia A Parkin; Ann E McDermott
Journal:  Biochim Biophys Acta Biomembr       Date:  2020-10-13       Impact factor: 4.019

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.